Transcatheter Aortic Valve Replacement 2016: A Modern-Day "through the Looking-Glass" Adventure

Journal of the American College of Cardiology

Volumn 67, Issue 12, 2016, Pages 1472-1487

  Vahl, Torsten P ^a   Kodali, Susheel K ^a   Leon, Martin B ^a  

^a Department of Medicine   (United States)

Author keywords

aortic stenosis; coronary artery disease; heart valve diseases; mitral valve; transcatheter heart valve

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; HIRULOG; WARFARIN;

ANTICOAGULANT THERAPY; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; BICUSPID AORTIC VALVE; BLEEDING; BLOOD VESSEL INJURY; CEREBROVASCULAR ACCIDENT; HUMAN; INTERMETHOD COMPARISON; LOW RISK PATIENT; MORTALITY; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; PROSTHESIS FAILURE; SURGICAL TECHNIQUE; SURVIVAL RATE; THERAPY EFFECT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR ACCESS; AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS; PATIENT SELECTION; RISK FACTOR; TRENDS;

AORTIC VALVE STENOSIS; HEART VALVE PROSTHESIS; HUMANS; PATIENT SELECTION; RISK FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84962303230     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.12.059     Document Type: Review

References (94)

1. L. Carroll Through the Looking Glass 1871 Macmillan London, UK
2. B. Iung, A. Cachier, G. Baron, and et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26 2005 2714 2720
3. V.H. Thourani, G. Ailawadi, W.Y. Szeto, and et al. Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study Ann Thorac Surg 91 2011 49 55 discussion 55-6
4. A. Cribier, H. Eltchaninoff, A. Bash, and et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description Circul, Structural Heart and Valve Center, 177 Fort Washington Avenue, 5th Floor, Room 5C-501, New York, New York 10032.ation 106 2002 3006 3008
5. R.A. Nishimura, C.M. Otto, R.O. Bonow, and et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 2014 e57 e185
6. A. Duncan, P. Ludman, W. Banya, and et al. Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the U.K. Transcatheter Aortic Valve Implantation Registry J Am Coll Cardiol Intv 8 2015 645 653
7. M. Gilard, H. Eltchaninoff, B. Iung, et al. for the FRANCE 2 Investigators Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med 366 2012 1705 1715
8. T. Walther, C.W. Hamm, G. Schuler, et al. for the GARY Executive Board Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry J Am Coll Cardiol 65 2015 2173 2180
9. M.B. Leon, C.R. Smith, M. Mack, et al. for the PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
10. J.J. Popma, D.H. Adams, M.J. Reardon, et al. for the CoreValve United States Clinical Investigators Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery J Am Coll Cardiol 63 2014 1972 1981
11. S.R. Kapadia, M.B. Leon, R.R. Makkar, et al. for the PARTNER Trial Investigators 5-Year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial Lancet 385 2015 2485 2491
12. Authors/Task Force Members, A. Vahanian, O. Alfieri, and et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg 42 2012 S1 S44
13. C.R. Smith, M.B. Leon, M.J. Mack, et al. for the PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
14. D.H. Adams, J.J. Popma, M.J. Reardon, and et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
15. M.J. Mack, M.B. Leon, C.R. Smith, et al. for the PARTNER 1 Trial Investigators 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial Lancet 385 2015 2477 2484
16. M.J. Reardon, D.H. Adams, N.S. Kleiman, and et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement J Am Coll Cardiol 66 2015 113 121
17. M.B. Leon, N. Piazza, E. Nikolsky, and et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269
18. A.P. Kappetein, S.J. Head, P. Généreux, and et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
19. Kodali S; PARTNER Trial Investigators. Clinical and echocardiographic outcomes at 30 days with the SAPIEN 3 TAVR system in inoperable, high-risk and intermediate-risk AS patients. Paper presented at: American College of Cardiology/i2 Scientific Session; March 15, 2015; San Diego, CA.
20. Herrmann HC. SAPIEN 3: evaluation of a balloon-expandable transcatheter aortic valve in high-risk and inoperable patients with aortic stenosis - one-year outcomes. Paper presented at: Transcatheter Cardiovascular Therapeutics; October 15, 2015; San Francisco, CA.
21. G. Athappan, R.D. Gajulapalli, P. Sengodan, and et al. Influence of transcatheter aortic valve replacement strategy and valve design on stroke after transcatheter aortic valve replacement: a meta-analysis and systematic review of literature J Am Coll Cardiol 63 2014 2101 2110
22. E. Durand, B. Borz, M. Godin, and et al. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes J Am Coll Cardiol Intv 5 2012 461 467
23. L.J. Motloch, D. Rottlaender, S. Reda, and et al. Local versus general anesthesia for transfemoral aortic valve implantation Clin Res Cardiol 101 2012 45 53
24. A.M. Kasel, A. Shivaraju, S. Schneider, and et al. Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance J Invasive Cardiol 26 2014 451 461
25. R.T. Hahn, L.D. Gillam, and S.H. Little Echocardiographic imaging of procedural complications during self-expandable transcatheter aortic valve replacement J Am Coll Cardiol Img 8 2015 319 336
26. R.T. Hahn, S. Kodali, E.M. Tuzcu, and et al. Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement J Am Coll Cardiol Img 8 2015 288 318
27. S.K. Kodali, M.R. Williams, C.R. Smith, et al. for the PARTNER Trial Investigators Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
28. J.M. Sinning, C. Hammerstingl, M. Vasa-Nicotera, and et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation J Am Coll Cardiol 59 2012 1134 1141
29. G. Athappan, E. Patvardhan, E.M. Tuzcu, and et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature J Am Coll Cardiol 61 2013 1585 1595
30. S. Kodali, P. Pibarot, P.S. Douglas, and et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards Sapien valve in the PARTNER trial: characterizing patients and impact on outcomes Eur Heart J 36 2015 449 456
31. P. Pibarot, R.T. Hahn, N.J. Weissman, and et al. Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme J Am Coll Cardiol Img 8 2015 340 360
32. L. Nombela-Franco, J. Rodés-Cabau, R. DeLarochellière, and et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve J Am Coll Cardiol Intv 5 2012 499 512
33. R.T. Hahn, P. Pibarot, J. Webb, and et al. Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve) J Am Coll Cardiol Intv 7 2014 781 789
34. V. Babaliaros, C. Devireddy, S. Lerakis, and et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis J Am Coll Cardiol Intv 7 2014 898 904
35. M. Barbanti, P. Capranzano, Y. Ohno, and et al. Early discharge after transfemoral transcatheter aortic valve implantation Heart 101 2015 1485 1490
36. D.A. Wood, R. Poulter, R. Cook, and et al. A Multidisciplinary, Multimodality, but Minimalist (3M) approach to transfemoral transcatheter aortic valve replacement facilitates safe next day discharge home in high risk patients: 1 year follow up J Am Coll Cardiol 64 2014 Abstract
37. A.B. Willson, J.G. Webb, T.M. Labounty, and et al. 3-Dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis J Am Coll Cardiol 59 2012 1287 1294
38. T.H. Yang, J.G. Webb, P. Blanke, and et al. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT J Am Coll Cardiol Intv 8 2015 462 471
39. O.K. Khalique, S.K. Kodali, J.M. Paradis, and et al. Aortic annular sizing using a novel 3-dimensional echocardiographic method: use and comparison with cardiac computed tomography Circ Cardiovasc Imaging 7 2014 155 163
40. P.C. Patsalis, F. Al-Rashid, T. Neumann, and et al. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing J Am Coll Cardiol Intv 6 2013 965 971
41. K. Bijuklic, T. Tübler, R.I. Low, and et al. Direct Flow medical valve EuroIntervention 8 Suppl Q 2012 Q75 Q78
42. J. Schofer, A. Colombo, S. Klugmann, and et al. Prospective multicenter evaluation of the Direct Flow Medical transcatheter aortic valve J Am Coll Cardiol 63 2014 763 768
43. I.T. Meredith, S.G. Worthley, R.J. Whitbourn, and et al. Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study EuroIntervention 9 2014 1264 1270
44. I.T. Meredith Am, D.L. Walters, N. Dumonteil, and et al. Transcatheter aortic valve replacement for severe symptomatic aortic stenosis using a repositionable valve system: 30-day primary endpoint results from the REPRISE II study J Am Coll Cardiol 64 2014 1339 1348
45. H. Treede, A. Rastan, M. Ferrari, and et al. JenaValve EuroIntervention 8 Suppl Q 2012 Q88 Q93
46. H. Treede, F.W. Mohr, S. Baldus, and et al. Transapical transcatheter aortic valve implantation using the JenaValve system: acute and 30-day results of the multicentre CE-mark study Eur J Cardiothorac Surg 41 2012 e131 e138
47. M. Abdel-Wahab, J. Mehilli, C. Frerker, et al. for the CHOICE investigators Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial JAMA 311 2014 1503 1514
48. M. Abdel-Wahab, F.J. Neumann, J. Mehilli, and et al. 1-Year outcomes after transcatheter aortic valve replacement with balloon-expandable versus self-expandable valves: results from the CHOICE randomized clinical trial J Am Coll Cardiol 66 2015 791 800
49. M. Barbanti, T.H. Yang, J. Rodés-Cabau, et al. for the CHOICE Investigators Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement Circulation 128 2013 244 253
50. M. Pasic, A. Unbehaun, S. Buz, and et al. Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention J Am Coll Cardiol Intv 8 2015 1 9
51. H.B. Ribeiro, J.G. Webb, R.R. Makkar, and et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry J Am Coll Cardiol 62 2013 1552 1562
52. P. Généreux, D.J. Cohen, M.R. Williams, and et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve) J Am Coll Cardiol 63 2014 1100 1109
53. P. Généreux, D.J. Cohen, M. Mack, and et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement J Am Coll Cardiol 64 2014 2605 2615
54. Z. Sergie, T. Lefèvre, E. Van Belle, and et al. Current periprocedural anticoagulation in transcatheter aortic valve replacement: could bivalirudin be an option? Rationale and design of the BRAVO 2/3 studies J Thromb Thrombolysis 35 2013 483 493
55. A. Linke, P. Wenaweser, U. Gerckens, et al. for the ADVANCE study investigators Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study Eur Heart J 35 2014 2672 2684
56. M.J. Mack, J.M. Brennan, R. Brindis, et al. for the STS/ACC TVT Registry Outcomes following transcatheter aortic valve replacement in the United States JAMA 310 2013 2069 2077
57. R. Lange, S. Bleiziffer, D. Mazzitelli, and et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients: a glimpse into the future J Am Coll Cardiol 59 2012 280 287
58. P. Wenaweser, S. Stortecky, S. Schwander, and et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation Eur Heart J 34 2013 1894 1905
59. N. Piazza, B. Kalesan, N. van Mieghem, and et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients J Am Coll Cardiol Intv 6 2013 443 451
60. P. D'Errigo, M. Barbanti, M. Ranucci, and et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: results from an intermediate risk propensity-matched population of the Italian OBSERVANT study Int J Cardiol 167 2013 1945 1952
61. G. Schymik, M. Heimeshoff, P. Bramlage, and et al. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1,141 patients with severe symptomatic aortic stenosis and less than high risk Catheter Cardiovasc Interv 86 2015 738 744
62. H.G. Thyregod, D.A. Steinbrüchel, N. Ihlemann, and et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial J Am Coll Cardiol 65 2015 2184 2194
63. J.M. Brennan, F.H. Edwards, Y. Zhao, et al. for the DEcIDE AVR (Developing Evidence to Inform Decisions about Effectiveness-Aortic Valve Replacement) Research Team Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database Circulation 127 2013 1647 1655
64. J.G. Webb, D.A. Wood, J. Ye, and et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves Circulation 121 2010 1848 1857
65. D. Dvir, J.G. Webb, S. Bleiziffer, et al. for the Valve-in-Valve International Data Registry Investigators Transcatheter aortic valve implantation in failed bioprosthetic surgical valves JAMA 312 2014 162 170
66. V.N. Bapat, R. Attia, and M. Thomas Effect of valve design on the stent internal diameter of a bioprosthetic valve: a concept of true internal diameter and its implications for the valve-in-valve procedure J Am Coll Cardiol Intv 7 2014 115 127
67. W.C. Roberts, and J.M. Ko Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation Circulation 111 2005 920 925
68. F. Philip, N.N. Faza, P. Schoenhagen, and et al. Aortic annulus and root characteristics in severe aortic stenosis due to bicuspid aortic valve and tricuspid aortic valves: implications for transcatheter aortic valve therapies Catheter Cardiovasc Interv 86 2015 E88 E98
69. D. Mylotte, T. Lefevre, L. Søndergaard, and et al. Transcatheter aortic valve replacement in bicuspid aortic valve disease J Am Coll Cardiol 64 2014 2330 2339
70. L. Nombela-Franco, H.B. Ribeiro, M. Urena, and et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era J Am Coll Cardiol 63 2014 2643 2658
71. S. Toggweiler, R.H. Boone, J. Rodés-Cabau, and et al. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation J Am Coll Cardiol 59 2012 2068 2074
72. L. Nombela-Franco, H. Eltchaninoff, R. Zahn, and et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis Heart 101 2015 1395 1405
73. M. Barbanti, J.G. Webb, R.T. Hahn, et al. for the Placement of Aortic Transcatheter Valve Trial Investigators Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A Circulation 128 2013 2776 2784
74. M. Barbanti, G.P. Ussia, and C. Tamburino Percutaneous treatment of aortic stenosis and mitral regurgitation in the same patient: first human cases description Catheter Cardiovasc Interv 78 2011 650 655
75. R.D. Madder, R.D. Safian, M. Gallagher, and et al. The first report of transcatheter aortic valve implantation and percutaneous mitral valve repair in the same patient J Am Coll Cardiol Intv 4 2011 824
76. V. Rudolph, J. Schirmer, O. Franzen, and et al. Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation Int J Cardiol 167 2013 716 720
77. M. Barbanti, R.K. Binder, D. Dvir, and et al. Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement Catheter Cardiovasc Interv 85 2015 677 684
78. B.R. Lindman, H.S. Maniar, W.A. Jaber, and et al. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort Circ Cardiovasc Interv 8 2015 e002073
79. A.H. Rapp, L.D. Hillis, R.A. Lange, and et al. Prevalence of coronary artery disease in patients with aortic stenosis with and without angina pectoris Am J Cardiol 87 2001 1216 1217 A7
80. J.M. Paradis, B. Labbé, and J. Rodés-Cabau Coronary artery disease and transcatheter aortic valve replacement: current treatment paradigms Coronary Artery Dis 26 2015 272 278
81. D.R. Holmes Jr., J.M. Brennan, J.S. Rumsfeld, and et al. Clinical outcomes at 1 year following transcatheter aortic valve replacement JAMA 313 2015 1019 1028
82. S. Stortecky, L. Buellesfeld, P. Wenaweser, and et al. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation Circ Cardiovasc Interv 6 2013 77 84
83. I.M. Barbash, S. Minha, I. Ben-Dor, and et al. Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation Catheter Cardiovasc Interv 85 2015 468 477
84. N. Bogunovic, W. Scholtz, C. Prinz, and et al. Percutaneous closure of left atrial appendage after transcatheter aortic valve implantation - an interventional approach to avoid anticoagulation therapy in elderly patients: TAVI and closure of LAA to avoid warfarin therapy EuroIntervention 7 2012 1361 1363
85. H.C. Herrmann, P. Pibarot, I. Hueter, and et al. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis Circulation 127 2013 2316 2326
86. L. Testa, A. Latib, M.L. Rossi, and et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry EuroIntervention 10 2014 739 745
87. D.A. Roy, U. Schaefer, V. Guetta, and et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation J Am Coll Cardiol 61 2013 1577 1584
88. D. Wendt, P. Kahlert, S. Pasa, and et al. Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits J Am Coll Cardiol Intv 7 2014 1159 1167
89. D.Y. Cheung, B. Duan, and J.T. Butcher Current progress in tissue engineering of heart valves: multiscale problems, multiscale solutions Expert Opin Biol Ther 15 2015 1155 1172
90. D.R. Johnston, E.G. Soltesz, N. Vakil, and et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants Ann Thorac Surg 99 2015 1239 1247
91. J. Rodés-Cabau, P. Kahlert, F.J. Neumann, and et al. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study J Am Coll Cardiol Intv 7 2014 1146 1155
92. M. Samim, P. Agostoni, J. Hendrikse, and et al. Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement J Thorac Cardiovasc Surg 149 2015 799 805.e1-2
93. D. Wendt, P. Kleinbongard, S. Knipp, and et al. Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic valve implantation Ann Thorac Surg 100 2015 686 691
94. A.J. Lansky, J. Schofer, D. Tchetche, and et al. A prospective randomized evaluation of the TriGuard HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial Eur Heart J 36 2015 2070 2078